StemPoint Capital LP
Overview
StemPoint Capital LP is a long-biased equity asset management firm dedicated to the global life sciences industry, with a focus on the biotechnology and pharmaceutical sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Quoin Pharmaceuticals | Sep 2026 | Series B | Co-investor |
| Surrozen | Mar 2025 | Private Placement | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is StemPoint Capital LP based?
StemPoint Capital LP is headquartered in New York City, New York, United States.
When was StemPoint Capital LP founded?
StemPoint Capital LP was founded in 2023.
How many portfolio companies does StemPoint Capital LP have?
StemPoint Capital LP has 2 portfolio companies in Caplight's dataset.
What are some companies in StemPoint Capital LP's portfolio?
Recent investments visible on Caplight include Quoin Pharmaceuticals, Surrozen.
What was StemPoint Capital LP's most recent investment?
StemPoint Capital LP's most recent investment on Caplight was in Quoin Pharmaceuticals in 2026.
What sectors does StemPoint Capital LP focus on?
StemPoint Capital LP focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does StemPoint Capital LP focus on?
StemPoint Capital LP typically invests at the Early stage.
What is StemPoint Capital LP's AUM?
StemPoint Capital LP's assets under management are estimated between $625.0M and $625.0M.